PR Newswire Clinical TrialsOriginal article
Theranica's AI Achieves 91% Precision on Next-Day Migraine Likelihood in Largest Study of Its Kind
Data ReadoutpositiveNerivioPositive
AI Analysis
Summary
Theranica's peer-reviewed study of 53,000 Nerivio users demonstrates an AI model achieving 91% precision in predicting next-day migraine likelihood based on 30-day headache patterns. The findings suggest patient headache history is a stronger predictor of migraine attacks than previously studied prodromal symptoms.
Clinical Trial Data
Primary Endpoint
Met
Patients
53,000
Outcome Details
AI model achieved 91% precision in predicting next-day migraine likelihood based on 30-day headache patterns in study of 53,000 Nerivio users
Importance:6/10
Sentiment:
0.75
artificial intelligencemigraine predictionpeer-reviewed studyreal-world evidence
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on September 23, 2026 1:06 PM